Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Antiangiogenic gene therapy evaluated in phase I/II glioblastoma study

Dec. 19, 2014

MicroRNAs identified as potential markers of epilepsy

Dec. 19, 2014

Promising data presented on novel drug for the treatment of pyruvate kinase deficiency

Dec. 19, 2014

Biscayne Pharmaceuticals present data on novel GHRH antagonist

Dec. 19, 2014

VPAC agonists show promising results as neuroprotectors in Parkinson's disease model

Dec. 18, 2014

Preliminary phase I/IIa data for an anticancer vaccine against multiple myeloma

Dec. 18, 2014

Preclinical results presented for BB-R12, a novel gene therapy for heart failure

Dec. 18, 2014

Preclinical data for RG-7888 support phase I investigation

Dec. 18, 2014

Taiho describes new androgen receptor antagonist for prostate cancer treatment

Dec. 18, 2014

Novel animal models to study human neurological disorders

Dec. 18, 2014

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...